W J Paget

2.5k total citations · 1 hit paper
70 papers, 2.0k citations indexed

About

W J Paget is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, W J Paget has authored 70 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 15 papers in Infectious Diseases and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in W J Paget's work include Influenza Virus Research Studies (41 papers), Respiratory viral infections research (31 papers) and Data-Driven Disease Surveillance (9 papers). W J Paget is often cited by papers focused on Influenza Virus Research Studies (41 papers), Respiratory viral infections research (31 papers) and Data-Driven Disease Surveillance (9 papers). W J Paget collaborates with scholars based in Netherlands, United Kingdom and Switzerland. W J Paget's co-authors include Madelon Kroneman, Adam Meijer, Gerrit A. van Essen, Douglas Fleming, François Schellevis, Ellen E. Stobberingh, T J Meerhoff, Susanne Dudman, Olav Hungnes and Peter Spreeuwenberg and has published in prestigious journals such as PLoS Medicine, The Lancet Infectious Diseases and Vaccine.

In The Last Decade

W J Paget

68 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study

2013 319 citations Madelon Kroneman, W J Paget et al. profile →

Peers

Countries citing papers authored by W J Paget

Since Specialization

Citations

This map shows the geographic impact of W J Paget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W J Paget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W J Paget more than expected).

Fields of papers citing papers by W J Paget

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W J Paget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W J Paget. The network helps show where W J Paget may publish in the future.

Co-authorship network of co-authors of W J Paget

This figure shows the co-authorship network connecting the top 25 collaborators of W J Paget. A scholar is included among the top collaborators of W J Paget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W J Paget. W J Paget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Economic Impact of Respiratory Syncytial Virus Infections in Children Under 5 Years of Age Attending Primary Care in Italy: A Prospective Cohort Study in Two Regions 2025 ·Influenza and Other Respiratory Viruses ·(unknown), Jojanneke van Summeren, (unknown), Elisabetta Pandolfi, Maria Chironna, Daniela Loconsole, Rolf Kramer, W J Paget, Caterina Rizzo	1
2	Assessing the Impact of Non‐Pharmaceutical Interventions During the COVID‐19 Pandemic on RSV Seasonality in Europe 2025 ·Influenza and Other Respiratory Viruses ·(unknown), Christos Baliatsas, Foekje F. Stelma, Harish Nair, W J Paget, Peter Spreeuwenberg	1
3	Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of disease 2015 ·Epidemiology and Infection ·Joris Adriaan Frank van Loenhout, Cornelia C. H. Wielders, G. Morroy, Michael J. Cox, Wim van der Hoek, Jeannine L.A. Hautvast, W J Paget, Jacobus van der Velden	17
4	Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureusin the community 2014 ·BMC Family Practice ·(unknown), W J Paget, Casper D. J. den Heijer, Ellen E. Stobberingh, Cathrien A. Bruggeman, François Schellevis	23
5	Serious long-term health consequences of Q-fever and Legionnaires' disease 2014 ·Journal of Infection ·Joris Adriaan Frank van Loenhout, (unknown), (unknown), Jan H. Vercoulen, Hans Bor, Koos van der Velden, W J Paget, Jeannine L.A. Hautvast	22
6	Q-fever patients suffer from impaired health status long after the acute phase of the illness: Results from a 24-month cohort study 2014 ·Journal of Infection ·Joris Adriaan Frank van Loenhout, Jeannine L.A. Hautvast, Jan H. Vercoulen, Reinier P. Akkermans, Clementine Wijkmans, Koos van der Velden, W J Paget	20
7	Assessing health status and quality of life of Q-fever patients: the Nijmegen Clinical Screening Instrument versus the Short Form 36 2013 ·Health and Quality of Life Outcomes ·(unknown), W J Paget, (unknown), Jeannine L.A. Hautvast, Koos van der Velden, Jan H. Vercoulen	9
8	Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study 2013 ·The Lancet Infectious Diseases ·(unknown), (unknown), W J Paget, Mike Pringle, Herman Goossens, Cathrien A. Bruggeman, François Schellevis, Ellen E. Stobberingh	172
9	Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date 2012 ·BMC Infectious Diseases ·(unknown), W J Paget, Jan H. Vercoulen, Clementine Wijkmans, Jeannine L.A. Hautvast, Koos van der Velden	33
10	The appropriateness of prescribing antibiotics in the community in Europe: study design 2011 ·BMC Infectious Diseases ·(unknown), Casper D. J. den Heijer, W J Paget, Ellen E. Stobberingh, Robert Verheij, Cathrien A. Bruggeman, Mike Pringle, Herman Goossens, François Schellevis	39
11	Progress in the surveillance of respiratory syncytial virus (RSV) in Europe: 2001-2008 2009 ·Eurosurveillance ·T J Meerhoff, A. Mosnier, François Schellevis, W J Paget, (unknown)	22
12	The impact of laboratory characteristics on molecular detection of respiratory syncytial virus in a European multicentre quality control study 2008 ·Clinical Microbiology and Infection ·T J Meerhoff, William G. Mackay, Adam Meijer, W J Paget, Hubert G.M. Niesters, Jan L. L. Kimpen, François Schellevis	4
13	Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries 2005 ·Vaccine ·Madelon Kroneman, Gerrit A. van Essen, W J Paget	106
14	Harmonising the virological surveillance of influenza in Europe: results of an 18-country survey 2004 ·Virus Research ·T J Meerhoff, W J Paget, (unknown), Jacobus van der Velden	13
15	Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands 2003 ·Vaccine ·Madelon Kroneman, Gerrit A. van Essen, (unknown), W J Paget, Robert Verheij	40
16	Heterogeneous case definitions used for the surveillance of influenza in Europe 2003 ·European Journal of Epidemiology ·(unknown), W J Paget, A. Mosnier, (unknown), Helmut Uphoff, Jacobus van der Velden, Tomás Vega, (unknown)	55
17	Activité grippale faible à modérée en Europe, et détection de nouveaux variants A(H1N2) et B durant l’hiver 2001-02 2002 ·Eurosurveillance ·W J Paget, T J Meerhoff, (unknown)	1
18	National Laboratory Reports of Chlamydia trachomatis Seriously Underestimate the Frequency of Genital Chlamydial Infections Among Women in Switzerland 2002 ·Sexually Transmitted Diseases ·W J Paget, Reinhard Zbinden, (unknown), Marcel Zwahlen, Christian Lengeler, D Stürchler, Hans C. Matter	18
19	The Swiss Network of Dermatology Policlinics HIV prevalence study: Rationale, characteristics and results (1990–1996) 1999 ·Sozial- und Präventivmedizin ·W J Paget, Véronique Batter, Marcel Zwahlen	3
20	Condom Use Among Patients Attending Six Sexually Transmitted Disease Clinics in Switzerland 1995 ·Sexually Transmitted Diseases ·W J Paget, Marcel Zwahlen, (unknown), Bernard Marti	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact